111 ROE 2018-2024 | YI
Current and historical return on equity (ROE) values for 111 (YI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| 111 ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-06-30 | $-0.05B | $-0.09B | 58.02% |
| 2024-03-31 | $-0.05B | $-0.08B | 70.90% |
| 2023-12-31 | $-0.06B | $-0.08B | 80.87% |
| 2023-09-30 | $-0.04B | $-0.07B | 65.08% |
| 2023-06-30 | $-0.04B | $-0.06B | 72.41% |
| 2023-03-31 | $-0.05B | $-0.06B | 88.89% |
| 2022-12-31 | $-0.06B | $-0.06B | 124.35% |
| 2022-09-30 | $-0.06B | $-0.05B | 162.03% |
| 2022-06-30 | $-0.09B | $-0.05B | 306.90% |
| 2022-03-31 | $-0.10B | $-0.04B | 869.57% |
| 2021-12-31 | $-0.11B | $-0.02B | -1135.14% |
| 2021-09-30 | $-0.11B | $-0.01B | -354.47% |
| 2021-06-30 | $-0.09B | $0.03B | -170.30% |
| 2021-03-31 | $-0.07B | $0.05B | -113.41% |
| 2020-12-31 | $-0.07B | $0.06B | -90.03% |
| 2020-09-30 | $-0.07B | $0.07B | -76.67% |
| 2020-06-30 | $-0.07B | $0.08B | -66.35% |
| 2020-03-31 | $-0.07B | $0.10B | -58.90% |
| 2019-12-31 | $-0.07B | $0.11B | -51.71% |
| 2019-09-30 | $-0.07B | $0.13B | -42.50% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.057B | $2.105B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.978B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.055B | 188.82 |
| Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
| Axonics (AXNX) | United States | $3.602B | 1762.00 |
| IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
| Privia Health (PRVA) | United States | $2.736B | 228.00 |
| Enovis (ENOV) | United States | $2.646B | 17.94 |
| Omnicell (OMCL) | United States | $2.263B | 74.03 |
| Azenta (AZTA) | United States | $2.242B | 127.33 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
| Schrodinger (SDGR) | United States | $1.422B | 0.00 |
| Phreesia (PHR) | United States | $1.252B | 0.00 |
| Standard BioTools (LAB) | United States | $0.830B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Talkspace (TALK) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
| Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| TruBridge (TBRG) | United States | $0.214B | 62.22 |
| P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| Zepp Health (ZEPP) | China | $0.050B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| CareCloud (CCLD) | United States | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |